Consensus document for lipid profile determination and reporting in Spanish clinical laboratories

被引：0

作者：

Velilla, Teresa Arrobas ^{[1
,2
]}

Guijarro, Carlos ^{[3
]}

Ruiz, Raquel Campuzano ^{[4
]}

Pinero, Manuel Rodriguez ^{[5
]}

Marcos, Jose Francisco Valderrama ^{[6
]}

Perez, Antonio Perez ^{[7
]}

Lopez, Manuel Antonio Botana ^{[8
]}

Lopez, Ana Morais ^{[9
]}

Donaire, Jose Antonio Garcia ^{[10
]}

Obaya, Juan Carlos ^{[11
]}

Guerra, Luis Castilla ^{[12
]}

Carratala, Vicente Pallares ^{[13
]}

Cabello, Isabel Egocheaga ^{[14
]}

Lazo, Mercedes Salgueira ^{[15
]}

Rodrigo, Maria Mar Castellanos ^{[16
]}

Prieto, Jose Maria Mostaza ^{[17
]}

Doblas, Juan Jose Gomez ^{[18
]}

Soto, Antonio Buno ^{[19
]}

机构：

[1] Hosp Univ Virgen Macarena Sevilla, Soc Espanola Med Lab SEQCML, Lab Bioquim Clin, Seville, Spain

[2] Univ Autonoma Chile, Fac Ciencias Salud, Santiago, Chile

[3] Univ Rey Juan Carlos, Hosp Univ Fdn Alcorcon, Unidad Med Interna, Soc Espanola Arteriosclerosis SEA, Madrid, Spain

[4] Hosp Univ Fdn Alcorcon, Asociac Riesgo Vasc & Rehabil Cardiaca Soc Espano, Soc Espanola Cardiol SEC, Unidad Cardiol, Madrid, Spain

[5] Hosp Univ Puerta Mar, Soc Espanola Angiol & Cirugia Vasc SEACV, Unidad Intercentros Cadiz Jerez Angiol & Cirug Va, Cadiz, Spain

[6] Hosp Reg Univ Malaga, Cirug Cardiovasc, Soc Espanola Cirug Cardiovasc & Endovasc SECCE, Malaga, Spain

[7] Hosp Santa Creu & Sant Pau, Serv Endocrinol & Nutr, Soc Espanola Diabet SED, Barcelona, Spain

[8] Hosp Univ Lucus Augusti, Secc Endocrinol, Soc Espanola Endocrinol & Nutr SEEN, Lugo, Spain

[9] Hosp Univ La Paz, Unidad Nutr Infantil & Enfermedades Metab, Soc Espanola Gastroenterol Hepatol & Nutr Pediat, Madrid, Spain

[10] Hosp Clin Univ San Carlos, Unidad Hipertens Arterial, Soc Espanola Hipertens Liga Espanola Lucha Hipert, Madrid, Spain

[11] Soc Espanola Med Familia & Comunitaria SEMFyC, Med Familiar & Comunitaria, CS La Chopera, Alcobendas, Madrid, Spain

[12] Univ Seville, Hosp Virgen Macarena, PCDV Dept Med, Sociedad Espanola Med Interna SEMI,Unidad Hiperte, Seville, Spain

[13] Univ Jaume 1, Unidad Vigilancia Salud, Dept Med, Soc Espanola Med Atenc Primaria SEMERG,Union Mutu, Castellon de La Plana, Spain

[14] Ctr Salud Isla Oza, Soc Espanola Med Gener & Familia SEMG, Med Familiar & Comunitaria, Serv Madrile Salud, Madrid, Spain

[15] Hosp Univ Virgen Macarena Sevilla, Soc Espanola Nefrol SEN, Unidad Nefrol, Seville, Spain

[16] Inst Invest Biomed Coruna, Serv Neurol Complejo Hosp Univ A Coru, Soc Espanola Neurol SEN, Coruna, Spain

[17] Hosp Paz Carlos III, Soc Espanola Arteriosclerosis SEA, Serv Med Interna, Madrid, Spain

[18] Hosp Univ Virgen Victoria, Soc Espanola Cardiol SEC, Serv Cardiol, Malaga, Spain

[19] Hosp Univ La Paz, Serv Analisis Clinicos, Soc Espanola Med Lab SEQCML, Madrid, Spain

来源：

HIPERTENSION Y RIESGO VASCULAR | 2023年 / 40卷 / 02期

关键词：

Consensus; Lipid panel; Cardiovascular disease; Biochemistry; Cholesterol; Lipids; Triglycerides; Lipoprotein (a); Apolipoprotein B; QUANTIFYING ATHEROGENIC LIPOPROTEINS; ARTERIOSCLEROSIS SEA; RECOMMENDATIONS; CHOLESTEROL; STATEMENT; METABOLISM; MANAGEMENT; SOCIETY; DYSLIPIDEMIA; INFLAMMATION;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Cardiovascular diseases (CVD) continue to be the main cause of death in our country. Adequate control of lipid metabolism disorders is a key challenge in cardiovascular prevention that is far from being achieved in real clinical practice. There is a great heterogeneity in the reports of lipid metabolism from Spanish clinical laboratories, which may contribute to its poor control. For this reason, a working group of the main scientific societies involved in the care of patients at vascular risk, has prepared this document with a consensus proposal on the determination of the basic lipid profile in cardiovascular prevention, recommendations for its realization and unification of criteria to incorporate the lipid control goals appropriate to the vascular risk of the patients in the laboratory reports.

引用

页码：75 / 84

页数：10

共 57 条

[1] [Anonymous], 1999, Human genetics program. Familial hypercholesterolemia FH): report of a second WHO consultation
[2] Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Cardiovascular Prevention Guidelines
Armario, Pedro
Brotons, Carlos
Elosua, Roberto
Alonso de Lecinana, Maria
Castro, Almudena
Clara, Albert
Cortes, Olga
Diaz Rodriguez, Angel
Herranz, Maria
Justo, Soledad
Lahoz, Carlos
Pedro-Botet, Juan
Perez Perez, Antonio
Santamaria, Rafael
Tresserras, Ricard
Aznar Lain, Susana
Angel Royo-Bordonada, Miguel
[J]. CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2021, 33 (02): : 85 - 107
[3] Arnett DK, 2019, CIRCULATION, V140, pE563, DOI [10.1161/CIR.0000000000000677, 10.1161/CIR.0000000000000678, 10.1016/j.jacc.2019.03.009, 10.1016/j.jacc.2019.03.010]
[4] National Lipid Association Annual Summary of Clinical Lipidology 2016
Bays, Harold E.
Jones, Peter H.
Orringer, Carl E.
Brown, W. Virgil
Jacobson, Terry A.
[J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2016, 10 (01) : S1 - S43
[5] Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
Boren, Jan
Chapman, M. John
Krauss, Ronald M.
Packard, Chris J.
Bentzon, Jacob F.
Binder, Christoph J.
Daemen, Mat J.
Demer, Linda L.
Hegele, Robert A.
Nicholls, Stephen J.
Nordestgaard, Brge G.
Watts, Gerald F.
Bruckert, Eric
Fazio, Sergio
Ference, Brian A.
Graham, Ian
Horton, Jay D.
Landmesser, Ulf
Laufs, Ulrich
Masana, Luis
Pasterkamp, Gerard
Raal, Frederick J.
Ray, Kausik K.
Schunkert, Heribert
Taskinen, Marja-Riitta
van de Sluis, Bart
Wiklund, Olov
Tokgozoglu, Lale
Catapano, Alberico L.
Ginsberg, Henry N.
[J]. EUROPEAN HEART JOURNAL, 2020, 41 (24) : 2313 - +
[6] Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies A Mendelian Randomization Analysis
Burgess, Stephen
Ference, Brian A.
Staley, James R.
Freitag, Daniel F.
Mason, Amy M.
Nielsen, Sune F.
Willeit, Peter
Young, Robin
Surendran, Praveen
Karthikeyan, Savita
Bolton, Thomas R.
Peters, James E.
Kamstrup, Pia R.
Tybjaerg-Hansen, Anne
Benn, Marianne
Langsted, Anne
Schnohr, Peter
Vedel-Krogh, Signe
Kobylecki, Camilla J.
Ford, Ian
Packard, Chris
Trompet, Stella
Jukema, J. Wouter
Sattar, Naveed
Di Angelantonio, Emanuele
Saleheen, Danish
Howson, Joanna M. M.
Nordestgaard, Borge G.
Butterworth, Adam S.
Danesh, John
[J]. JAMA CARDIOLOGY, 2018, 3 (07) : 619 - 627
[7] HEART UK consensus statement on Lipoprotein(a): A call to action
Cegla, Jaimini
Neely, R. Dermot G.
France, Michael
Ferns, Gordon
Byrne, Chris D.
Halcox, Julian
Datta, Dev
Capps, Nigel
Shoulders, Carol
Qureshi, Nadeem
Rees, Alan
Main, Linda
Cramb, Robert
Viljoen, Adie
Payne, Jules
Soran, Handrean
[J]. ATHEROSCLEROSIS, 2019, 291 : 62 - 70
[8] Conrad N, 2022, LANCET, V400, P733, DOI 10.1016/S0140-6736(22)01349-6
[9] BLOOD LIPID MEASUREMENTS - VARIATIONS AND PRACTICAL UTILITY
COOPER, GR
MYERS, GL
SMITH, SJ
SCHLANT, RC
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (12): : 1652 - 1660
[10] Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries
De Backer, Guy
Jankowski, Piotr
Kotseva, Kornelia
Mirrakhimov, Erkin
Reiner, Zeljko
Ryden, Lars
Tokgozoglu, Lale
Wood, David
De Bacquer, Dirk
Abreu, A.
Aguiar, C.
Badariene, J.
Bruthans, J.
Castro Conde, A.
Cifkova, R.
Crowley, J.
Davletov, K.
De Smedt, D.
De Sutter, J.
Deckers, J. W.
Dilic, M.
Dolzhenko, M.
Druais, H.
Dzerve, V.
Erglis, A.
Fras, Z.
Gaita, D.
Gotcheva, N.
Grobbee, D. E.
Gyberg, V.
Ali, H. Hasan
Heuschmann, P.
Hoes, A. W.
Lalic, N.
Lehto, S.
Lovic, D.
Maggioni, A. P.
Mancas, S.
Marques-Vidal, P.
Mellbin, L.
Milicic, D.
Oganov, R.
Pogosova, N.
Stagmo, M.
Stoerk, S.
Sundvall, J.
Tsioufis, K.
Vulic, D.
Wood, D. A.
Jennings, C.
[J]. ATHEROSCLEROSIS, 2019, 285 : 135 - 146

← 1 2 3 4 5 6 →